Older Prostate Cancer Patients’ Chances Improved in 1990s

Since prostate cancer screening increased, more older men are surviving the disease through Active Surveillance, aka “Watchful Waiting”

Older men who were diagnosed with prostate cancer after early 1990 and were treated with conservative management (“Watchful Waiting”) lived significantly longer than men in similar situation 10 or 20 years previous to that.

This is the finding of a large new study based on Medicare patients’ records. The study is published in September 15 issue of the Journal of the American Medical Association (JAMA) by a team at The Cancer Institute of New Jersey (CINJ).

AUA New Guidelines on Prostate Cancer Screening

The American Urological Association (AUA) today issued new clinical guidance about prostate cancer screening. The guidelines were announced at the association’s annual meeting by Peter Carroll, chair of the panel that developed the Statement.  The AUA states that its guidelines directly contrast with recent recommendations issued by other major groups.

AUA advises that the prostate-specific antigen (PSA) test should be offered to well-informed men aged 40 years or older who have a life expectancy of at least 10 years.